Risogenes Biosciences (Opc) Private Limited

Develops high-yielding seeds and agricultural technology for agro-based industries.

2018 | Hyderabad, Telangana (India) | Active
Last Updated: December 22, 2024

Risogenes Biosciences (Opc) Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 8 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth %
  • Profit Growth 99.90%
  • Ebitda 99.90%
  • Net Worth 99.88%
  • Total Assets -99.90%

About Risogenes Biosciences (Opc)

Risogenes Biosciences (Opc) Private Limited (RBOPL) is a Company incorporated in India on 31 May 2018 (Six years and eight months 16 days old ). Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Life Sciences Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Rajeshwari Ramanan serves as a director at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U73100TG2018OPC124850

  • Company No.

    124850

  • Incorporation Date

    31 May 2018

  • Date of AGM

    -

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Life Sciences

Who are the key members and board of directors at Risogenes Biosciences (Opc)?

Board Members (1)

Name Designation Appointment Date Status
Rajeshwari Ramanan Country flag representing In Director 31-May-2018 Current

Financial Performance of Risogenes Biosciences (Opc).

Risogenes Biosciences (Opc) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 99.9% increase in profit. The company's net worth Soared by an impressive increase of 99.88%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-99.90%
Profit or Loss
99.90%
Net Worth
99.88%
EBITDA
99.90%

What is the Ownership and Shareholding Structure of Risogenes Biosciences (Opc)?

In 2021, Risogenes Biosciences (Opc) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Risogenes Biosciences (Opc)?

Unlock and access historical data on people associated with Risogenes Biosciences (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Risogenes Biosciences (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Risogenes Biosciences (Opc)'s trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Risogenes Biosciences (Opc)

Recent activity within the organization

  • Balance Sheet

    Risogenes Biosciences (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.

    31 Mar 2023

  • Director Appointment

    Rajeshwari Ramanan was appointed as a Director was appointed as a Director on 31 May 2018 & has been associated with this company since 6 years 8 months .

    31 May 2018

  • Company Incorporation

    Risogenes Biosciences (Opc) Private Limited was registered on 31 May 2018 with Roc Hyderabad & aged 6 years 8 months as per MCA records.

    31 May 2018

Frequently asked questions

  • Risogenes Biosciences (Opc) Private Limited was incorporated on 31 May 2018.

  • The authorized share capital of Risogenes Biosciences (Opc) Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Currently 1 director is associated with Risogenes Biosciences (Opc) Private Limited.

    • Rajeshwari Ramanan
  • As per Ministry of Corporate Affairs (Mca), the registered address of Risogenes Biosciences (Opc) Private Limited is 68 Park View Enclave Manovikasnagar Bowenpally, India, Secunderabad, Telangana, 500009.

  • The corporate identification number (CIN) of Risogenes Biosciences (Opc) Private Limited is U73100TG2018OPC124850 and the company number is 124850 as per Ministry of Corporate Affairs (MCA).

  • The financial reports for the fiscal year 2022 indicates that The net worth of Risogenes Biosciences (Opc) Private Limited has experienced an upsurge of 99.88%.

  • The most recent Balance Sheet for Risogenes Biosciences (Opc) Private Limited was filed with the ROC on 31 Mar 2023.